Advanced in Age-Related Macular Degeneration (ARMD)

Katrin Lorenz

Mainz, RP, DE 
Advanced in Age-Related Macular Degeneration (ARMD)
Mainz, RP, DE 
OverviewLocationsClinical Research

Overview

Katrin Lorenz practices in Mainz, Germany. Ms. Lorenz is rated as an Advanced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Pigment-Dispersion Syndrome, Ocular Hypertension (OHT), Glaucoma, Trabeculectomy, and Iridectomy.

Her clinical research consists of co-authoring 82 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 17 articles and participated in 1 clinical trial in the study of Age-Related Macular Degeneration (ARMD).

Gender
Female

Locations

Mainz, RP 55131, Germany
Other Locations
Gutenberg, RP, Germany
Dresden, SN 01307, Germany
R&D, Industriepark Hoechst, Frankfurt Am Main, HE, Germany
Munich, BY, Germany
Heidelberg, BW, Germany
Bochum, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE II)
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE II)
Enrollment Status: Completed
Publish Date: September 02, 2021
Intervention Type: Device
Study Phase: Not Applicable
Comparison of Sensimed Triggerfish (TF) 24 Hour Monitoring of the Eye in Glaucoma Patients Before and After Trabeculectomy
Comparison of Sensimed Triggerfish (TF) 24 Hour Monitoring of the Eye in Glaucoma Patients Before and After Trabeculectomy
Enrollment Status: Completed
Publish Date: September 01, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Enrollment Status: Terminated
Publish Date: July 20, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

82 Total Publications

CRIMSON : A multicentre randomised, sham-controlled, double-masked, 72-week trial to study the safety, tolerability, pharmacokinetics, and efficacy of 3 dosing regimens of intravitreal BI 764524 in patients with moderate to severe non-proliferative diabetic retinopathy
CRIMSON : A multicentre randomised, sham-controlled, double-masked, 72-week trial to study the safety, tolerability, pharmacokinetics, and efficacy of 3 dosing regimens of intravitreal BI 764524 in patients with moderate to severe non-proliferative diabetic retinopathy
Journal: Die Ophthalmologie
Published: October 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lorenz's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile